Ayurcann Holdings Financials
AYURF Stock | USD 0.02 0.03 57.69% |
With this module, you can analyze Ayurcann financials for your investing period. You should be able to track the changes in Ayurcann Holdings individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Ayurcann |
Understanding current and past Ayurcann Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ayurcann Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in Ayurcann Holdings' assets may result in an increase in income on the income statement.
The data published in Ayurcann Holdings' official financial statements typically reflect Ayurcann Holdings' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Ayurcann Holdings' quantitative information. For example, before you start analyzing numbers published by Ayurcann accountants, it's essential to understand Ayurcann Holdings' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Ayurcann Holdings Stock Summary
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company was founded in 2018 and is headquartered in Pickering, Canada. Ayurcann Hldgs is traded on OTC Exchange in the United States.Instrument | USA OTC Stock View All |
Exchange | OTCQB Exchange |
Business Address | 1080 Brock Road, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | ayurcann.com |
Currency | USD - US Dollar |
Ayurcann Holdings Key Financial Ratios
There are many critical financial ratios that Ayurcann Holdings' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ayurcann Holdings Corp reports annually and quarterly.Return On Equity | -0.71 | |||
Return On Asset | -0.33 | |||
Z Score | 73.0 |
Ayurcann Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ayurcann Holdings's current stock value. Our valuation model uses many indicators to compare Ayurcann Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ayurcann Holdings competition to find correlations between indicators driving Ayurcann Holdings's intrinsic value. More Info.Ayurcann Holdings Corp is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ayurcann Holdings' earnings, one of the primary drivers of an investment's value.Ayurcann Holdings Corp Systematic Risk
Ayurcann Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ayurcann Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Ayurcann Holdings Corp correlated with the market. If Beta is less than 0 Ayurcann Holdings generally moves in the opposite direction as compared to the market. If Ayurcann Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ayurcann Holdings Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ayurcann Holdings is generally in the same direction as the market. If Beta > 1 Ayurcann Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Ayurcann Holdings November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ayurcann Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ayurcann Holdings Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ayurcann Holdings Corp based on widely used predictive technical indicators. In general, we focus on analyzing Ayurcann OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ayurcann Holdings's daily price indicators and compare them against related drivers.
Downside Deviation | 30.25 | |||
Information Ratio | (0) | |||
Maximum Drawdown | 118.41 | |||
Value At Risk | (20.81) | |||
Potential Upside | 20.32 |
Complementary Tools for Ayurcann OTC Stock analysis
When running Ayurcann Holdings' price analysis, check to measure Ayurcann Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ayurcann Holdings is operating at the current time. Most of Ayurcann Holdings' value examination focuses on studying past and present price action to predict the probability of Ayurcann Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ayurcann Holdings' price. Additionally, you may evaluate how the addition of Ayurcann Holdings to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |